Pulmonary nodule laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
The use of biomarker may be useful in the risk stratification for solitary pulmonary nodule, biomarkers such as: | |||
:*Carcinoembryonic antigen | |||
:*Alpha-1 antitrypsin | |||
:*Squamous cell carcinoma antigen | |||
The measurement of biomarkers may be useful for benign diseases, markers such as: | |||
:*Angiotensin converting enzyme | |||
:*Connective tissue disease markers | |||
==References== | ==References== |
Revision as of 22:40, 17 March 2016
Pulmonary Nodule Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pulmonary nodule laboratory findings On the Web |
American Roentgen Ray Society Images of Pulmonary nodule laboratory findings |
Risk calculators and risk factors for Pulmonary nodule laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]}Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Laboratory Findings
The use of biomarker may be useful in the risk stratification for solitary pulmonary nodule, biomarkers such as:
- Carcinoembryonic antigen
- Alpha-1 antitrypsin
- Squamous cell carcinoma antigen
The measurement of biomarkers may be useful for benign diseases, markers such as:
- Angiotensin converting enzyme
- Connective tissue disease markers